S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
NYSE:CFX

Colfax Stock Forecast, Price & News

$44.13
+0.02 (+0.05%)
(As of 01/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$43.39
$44.81
50-Day Range
$42.94
$52.17
52-Week Range
$36.72
$54.67
Volume
882,897 shs
Average Volume
962,351 shs
Market Capitalization
$6.28 billion
P/E Ratio
62.16
Dividend Yield
N/A
Beta
2.15
30 days | 90 days | 365 days | Advanced Chart
Receive CFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Colfax and its competitors with MarketBeat's FREE daily newsletter.


Colfax logo

About Colfax

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pumps & pumping equipment
Sub-Industry
Industrial Machinery
CUSIP
19401410
Employees
15,400
Year Founded
1995

Sales & Book Value

Annual Sales
$3.07 billion
Cash Flow
$3.71 per share
Book Value
$30.29 per share

Profitability

Net Income
$42.63 million
Pretax Margin
4.33%

Debt

Price-To-Earnings

Miscellaneous

Free Float
128,677,000
Market Cap
$6.28 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Today
1/20/2022
Next Earnings (Estimated)
2/17/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.35 out of 5 stars

Industrial Products Sector

99th out of 248 stocks

Pumps & Pumping Equipment Industry

5th out of 8 stocks

Analyst Opinion: 2.1Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -












Colfax (NYSE:CFX) Frequently Asked Questions

Is Colfax a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colfax in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Colfax stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CFX, but not buy additional shares or sell existing shares.
View analyst ratings for Colfax
or view top-rated stocks.

How has Colfax's stock price been impacted by Coronavirus (COVID-19)?

Colfax's stock was trading at $25.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CFX stock has increased by 72.1% and is now trading at $44.13.
View which stocks have been most impacted by COVID-19
.

When is Colfax's next earnings date?

Colfax is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Colfax
.

How were Colfax's earnings last quarter?

Colfax Co. (NYSE:CFX) issued its earnings results on Thursday, November, 4th. The industrial products company reported $0.54 EPS for the quarter, meeting the consensus estimate of $0.54. The industrial products company had revenue of $965.89 million for the quarter, compared to analysts' expectations of $958.44 million. Colfax had a net margin of 2.92% and a trailing twelve-month return on equity of 7.28%. Colfax's revenue for the quarter was up 19.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.41 EPS.
View Colfax's earnings history
.

What guidance has Colfax issued on next quarter's earnings?

Colfax updated its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share (EPS) guidance of $2.100-$2.100 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.150. The company issued revenue guidance of -.

What price target have analysts set for CFX?

8 Wall Street analysts have issued 1 year price objectives for Colfax's stock. Their forecasts range from $41.00 to $60.00. On average, they expect Colfax's share price to reach $50.13 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price.
View analysts' price targets for Colfax
or view top-rated stocks among Wall Street analysts.

Who are Colfax's key executives?

Colfax's management team includes the following people:
  • Matthew L. Trerotola, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Christopher Michael Hix, Chief Financial Officer & Executive VP-Finance
  • Shyam Kambeyanda, Senior Vice President & CEO-ESAB (LinkedIn Profile)
  • Patricia A. Lang, Chief Human Resources Officer & Senior VP
  • Bradley J. Tandy, Secretary, Senior VP & General Counsel

What is Matthew Trerotola's approval rating as Colfax's CEO?

2 employees have rated Colfax CEO Matthew Trerotola on Glassdoor.com. Matthew Trerotola has an approval rating of 54% among Colfax's employees. This puts Matthew Trerotola in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Colfax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colfax investors own include Endologix (ELGX), (APA), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Charles Schwab (SCHW), Accenture (ACN), (HON), Micron Technology (MU) and Semtech (SMTC).

What is Colfax's stock symbol?

Colfax trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFX."

Who are Colfax's major shareholders?

Colfax's stock is owned by a number of institutional and retail investors. Top institutional investors include Louisiana State Employees Retirement System (0.02%), New Mexico Educational Retirement Board (0.02%), State of Alaska Department of Revenue (0.01%), Crossmark Global Holdings Inc. (0.01%), Boenning & Scattergood Inc. (0.01%) and Symmetry Partners LLC (0.01%). Company insiders that own Colfax stock include Brady Shirley, Christopher M Hix, Daniel A Pryor, Douglas J Pitts, Jason Maclean, Liam Kelly, Matthew L Trerotola, Mitchell P Rales, Mitchell P Rales, Patricia A Lang, Rajiv Vinnakota and Shyam Kambeyanda.
View institutional ownership trends for Colfax
.

Which institutional investors are selling Colfax stock?

CFX stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP, Symmetry Partners LLC, and State of Alaska Department of Revenue. Company insiders that have sold Colfax company stock in the last year include Christopher M Hix, Daniel A Pryor, Matthew L Trerotola, Patricia A Lang, Rajiv Vinnakota, and Shyam Kambeyanda.
View insider buying and selling activity for Colfax
or view top insider-selling stocks.

Which institutional investors are buying Colfax stock?

CFX stock was purchased by a variety of institutional investors in the last quarter, including Spire Wealth Management, New Mexico Educational Retirement Board, Boenning & Scattergood Inc., Crossmark Global Holdings Inc., Louisiana State Employees Retirement System, Farmers & Merchants Investments Inc., and Lindbrook Capital LLC. Company insiders that have bought Colfax stock in the last two years include Brady Shirley, Liam Kelly, and Mitchell P Rales.
View insider buying and selling activity for Colfax
or or view top insider-buying stocks.

How do I buy shares of Colfax?

Shares of CFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Colfax's stock price today?

One share of CFX stock can currently be purchased for approximately $44.13.

How much money does Colfax make?

Colfax has a market capitalization of $6.28 billion and generates $3.07 billion in revenue each year. The industrial products company earns $42.63 million in net income (profit) each year or $0.71 on an earnings per share basis.

How many employees does Colfax have?

Colfax employs 15,400 workers across the globe.

Does Colfax have any subsidiaries?

The following companies are subsidiares of Colfax: DJO Global.

When was Colfax founded?

Colfax was founded in 1995.

What is Colfax's official website?

The official website for Colfax is www.colfaxcorp.com.

Where are Colfax's headquarters?

How can I contact Colfax?

Colfax's mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company can be reached via phone at (301) 323-9000, via email at [email protected], or via fax at 301-323-9001.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.